167 related articles for article (PubMed ID: 17617370)
1. Aequorin luminescence-based assay for 5-hydroxytryptamine (serotonin) type 3 receptor characterization.
Walstab J; Combrink S; Brüss M; Göthert M; Niesler B; Bönisch H
Anal Biochem; 2007 Sep; 368(2):185-92. PubMed ID: 17617370
[TBL] [Abstract][Full Text] [Related]
2. Naturally occurring variants in the HTR3B gene significantly alter properties of human heteromeric 5-hydroxytryptamine-3A/B receptors.
Walstab J; Hammer C; Bönisch H; Rappold G; Niesler B
Pharmacogenet Genomics; 2008 Sep; 18(9):793-802. PubMed ID: 18698232
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the novel human serotonin receptor subunits 5-HT3C,5-HT3D, and 5-HT3E.
Niesler B; Walstab J; Combrink S; Möller D; Kapeller J; Rietdorf J; Bönisch H; Göthert M; Rappold G; Brüss M
Mol Pharmacol; 2007 Jul; 72(1):8-17. PubMed ID: 17392525
[TBL] [Abstract][Full Text] [Related]
4. A high-throughput glow-type aequorin assay for measuring receptor-mediated changes in intracellular calcium levels.
George SE; Schaeffer MT; Cully D; Beer MS; McAllister G
Anal Biochem; 2000 Nov; 286(2):231-7. PubMed ID: 11067745
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and pharmacological characterization of serotonin 5-HT(3A) receptor subtype in dog.
Jensen TN; Nielsen J; Frederiksen K; Ebert B
Eur J Pharmacol; 2006 May; 538(1-3):23-31. PubMed ID: 16647053
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the naturally occurring Arg344His variant of the human 5-HT 3A receptor.
Combrink S; Kostanian A; Walstab J; Barann M; Brüss M; Göthert M; Bönisch H
Pharmacol Rep; 2009; 61(5):785-97. PubMed ID: 19904001
[TBL] [Abstract][Full Text] [Related]
7. Development of an aequorin luminescence calcium assay for high-throughput screening using a plate reader, the LumiLux.
Menon V; Ranganathn A; Jorgensen VH; Sabio M; Christoffersen CT; Uberti MA; Jones KA; Babu PS
Assay Drug Dev Technol; 2008 Dec; 6(6):787-93. PubMed ID: 19090690
[TBL] [Abstract][Full Text] [Related]
8. Development of a Ca(2+)-activated photoprotein, Photina, and its application to high-throughput screening.
Bovolenta S; Foti M; Lohmer S; Corazza S
J Biomol Screen; 2007 Aug; 12(5):694-704. PubMed ID: 17517900
[TBL] [Abstract][Full Text] [Related]
9. General anesthetic-induced channel gating enhancement of 5-hydroxytryptamine type 3 receptors depends on receptor subunit composition.
Solt K; Stevens RJ; Davies PA; Raines DE
J Pharmacol Exp Ther; 2005 Nov; 315(2):771-6. PubMed ID: 16081679
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner.
Rammes G; Eisensamer B; Ferrari U; Shapa M; Gimpl G; Gilling K; Parsons C; Riering K; Hapfelmeier G; Bondy B; Zieglgänsberger W; Holsboer F; Rupprecht R
Mol Psychiatry; 2004 Sep; 9(9):846-58, 818. PubMed ID: 15024394
[TBL] [Abstract][Full Text] [Related]
11. Application of new semisynthetic aequorins with long half-decay time of luminescence to G-protein-coupled receptor assay.
Inouye S; Iimori R; Sahara Y; Hisada S; Hosoya T
Anal Biochem; 2010 Dec; 407(2):247-52. PubMed ID: 20800051
[TBL] [Abstract][Full Text] [Related]
12. Use of bioluminescent aequorin for the pharmacological characterization of 5HT receptors.
Schaeffer MT; Cully D; Chou M; Liu J; Van der Ploeg LH; Fong TM
J Recept Signal Transduct Res; 1999 Nov; 19(6):927-38. PubMed ID: 10533981
[TBL] [Abstract][Full Text] [Related]
13. An automated aequorin luminescence-based functional calcium assay for G-protein-coupled receptors.
Ungrin MD; Singh LM; Stocco R; Sas DE; Abramovitz M
Anal Biochem; 1999 Jul; 272(1):34-42. PubMed ID: 10405290
[TBL] [Abstract][Full Text] [Related]
14. Bioluminescence immunoassay for angiotensin II using aequorin as a label.
Qu X; Deo SK; Dikici E; Ensor M; Poon M; Daunert S
Anal Biochem; 2007 Dec; 371(2):154-61. PubMed ID: 17931588
[TBL] [Abstract][Full Text] [Related]
15. The use of aequorins to record and visualize Ca(2+) dynamics: from subcellular microdomains to whole organisms.
Webb SE; Rogers KL; Karplus E; Miller AL
Methods Cell Biol; 2010; 99():263-300. PubMed ID: 21035690
[TBL] [Abstract][Full Text] [Related]
16. High-Throughput Screening Using Photoluminescence Probe to Measure Intracellular Calcium Levels.
Feno S; Di Marco G; De Mario A; Monticelli H; Reane DV
Methods Mol Biol; 2019; 1925():1-14. PubMed ID: 30674012
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the 5-HT2b receptor in evaluation of aequorin detection of calcium mobilization for miniaturized GPCR high-throughput screening.
Gilchrist MA; Cacace A; Harden DG
J Biomol Screen; 2008 Jul; 13(6):486-93. PubMed ID: 18566482
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of 5-HT3C, 5-HT3D and 5-HT3E receptor subunits: evolution, distribution and function.
Holbrook JD; Gill CH; Zebda N; Spencer JP; Leyland R; Rance KH; Trinh H; Balmer G; Kelly FM; Yusaf SP; Courtenay N; Luck J; Rhodes A; Modha S; Moore SE; Sanger GJ; Gunthorpe MJ
J Neurochem; 2009 Jan; 108(2):384-96. PubMed ID: 19012743
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands.
Ziemek R; Brennauer A; Schneider E; Cabrele C; Beck-Sickinger AG; Bernhardt G; Buschauer A
Eur J Pharmacol; 2006 Dec; 551(1-3):10-8. PubMed ID: 17027743
[TBL] [Abstract][Full Text] [Related]
20. Naturally occurring variations in the human 5-HT3A gene profoundly impact 5-HT3 receptor function and expression.
Krzywkowski K; Jensen AA; Connolly CN; Bräuner-Osborne H
Pharmacogenet Genomics; 2007 Apr; 17(4):255-66. PubMed ID: 17496724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
